Company / Shares Outstanding
Matinas BioPharma Holdings, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
4.3M
FY2024
5-year range
4.3M / 217.3M
FY2020-FY2024
Trend
-98.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 216269450.00 to 4345291.00 over the past 2 years.
Based on SEC 10-K filings.
4345291.00 in FY2024 with a 5-year CAGR of -47.9%.
Improved from 216269450.00 to 4345291.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -72.1%
- 5-Year CAGR
- -47.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shares outstanding decreased 98.0% year-over-year.
- Peak shares outstanding was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 4.3M | -98.0% |
| FY2023 | 217.3M | +0.5% |
| FY2022 | 216.3M | +8.1% |
| FY2021 | 200.1M | +22.7% |
| FY2020 | 163.2M | +44.0% |
| FY2019 | 113.3M | +21.3% |
| FY2018 | 93.4M | +60.5% |
| FY2017 | 58.2M | +1.7% |
| FY2016 | 57.2M | +77.1% |
| FY2015 | 32.3M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026